- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$168.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$54,675.00
7D
6.2%
1Y
40.6%
Bristol-Myers Squibb
Market Cap: US$132.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$21.97
7D
-2.4%
1Y
44.1%
Bristol-Myers Squibb
Market Cap: AR$130.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$34,100.00
7D
1.2%
1Y
63.0%
Amgen
Market Cap: US$225.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$14.39
7D
3.2%
1Y
50.5%
Bayer
Market Cap: AR$47.2b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$27,020.00
7D
n/a
1Y
n/a
Amgen
Market Cap: AR$225.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$22,020.00
7D
3.6%
1Y
74.1%
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$6.87
7D
0.7%
1Y
n/a
GSK
Market Cap: US$74.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.18
7D
-1.6%
1Y
43.4%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,540.00
7D
2.1%
1Y
n/a
GSK
Market Cap: AR$74.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$19,920.00
7D
-2.9%
1Y
57.8%
Gilead Sciences
Market Cap: US$168.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$35.72
7D
7.0%
1Y
16.9%
Tempus AI
Market Cap: AR$9.9b
Operates as a healthcare technology company in the United States.
TEM
AR$7,180.00
7D
18.2%
1Y
-8.2%
AstraZeneca
Market Cap: AR$181.6b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$62,175.00
7D
-2.0%
1Y
21.2%
Vertex Pharmaceuticals
Market Cap: AR$133.3b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,085.00
7D
7.4%
1Y
59.5%
Novartis
Market Cap: US$235.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$38.67
7D
-2.6%
1Y
32.0%
Novartis
Market Cap: AR$235.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$60,125.00
7D
-1.4%
1Y
49.8%
Vertex Pharmaceuticals
Market Cap: US$133.3b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.29
7D
7.0%
1Y
37.6%
AstraZeneca
Market Cap: US$181.6b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$40.97
7D
-1.8%
1Y
4.9%
Tempus AI
Market Cap: US$9.9b
Operates as a healthcare technology company in the United States.
TEMD
US$4.74
7D
16.3%
1Y
-21.5%